KCT0000042招募中未知
A randomized, multi center, phase IIIb open-label study to evaluate the efficacy of sequential therapy of Peginterferon alfa-2a(Pegasys(TM)) following Entecavir compared with Peginterferon alfa-2a monotherapy in patient with HBeAg positive chronic hepatitis B
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 228
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Chronic hepatitis B patients with HBeAg positive, HBsAg positive, HBV DNA > 100,000 copies/ml, anti-HBs negative, serum ALT exceeding 2 X ULN but less than 10 X ULN.
排除标准
- •Patient infected concurrently with HCV, HDV and HIV
- •or patient with a history of antiviral treatment for Hepatitis B
- •or patient with hepatic decompensation.
研究者
相似试验
进行中（未招募）
不适用
A randomized, multi-center Phase IIIb, open label, study of letrozole vs anastrozole in the adjuvant treatment of postmenopausal women with hormone receptor and node positive breast cancerHormone receptor positive breast cancer in postmenopausal womenMedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-004263-35-ITOVARTIS FARMA4,000
进行中（未招募）
不适用
An open-label, randomized, phase IIIB, multicenter trial to evaluate the pharmacodynamic parameters of intubation bolus, and bolus and infusion maintenance doses of Zemuron® in pediatric and adolescent subjectsot applicableEUCTR2005-002926-67-DEV Organon120
进行中（未招募）
不适用
Evaluation of immunogenicity and safety of two 2-dose Human Papillomavirus (HPV) vaccine schedules in 9-14 year old girls.EUCTR2011-000757-22-DEGlaxoSmithKline Biologicals1,428
进行中（未招募）
不适用
Evaluation of immunogenicity and safety of two 2-dose Human Papillomavirusthe (HPV) vaccine schedules in 9-14 years old girls.EUCTR2011-000757-22-ITGLAXO SMITHKLINE1,428
进行中（未招募）
不适用
An open-label, randomized, multicenter Phase IIIb study to assess the efficacy, safety and tolerance of BERIPLEX® P/N compared with plasma for rapid reversal ofcoagulopathy induced by coumarin derivatives in subjects with acute major bleedingTherapy of major bleeding resulting from an acquired deficiency of vitamin K-dependent coagulation factors and proteins C and S due to use of oral anticoagulation therapyMedDRA version: 9.1Level: LLTClassification code 10009789Term: Coagulation factors decreasedMedDRA version: 9.1Level: LLTClassification code 10005103Term: BleedingEUCTR2007-007861-19-BGCSL Behring GmbH176